The role of two dimensional speckle tracking echocardiography in determining cardiac prognosis and monitoring enzyme replacement therapy efficacy in patients with Anderson–Fabry disease

This publication has 12 references indexed in Scilit:

• Cardiac Involvement in Fabry Disease
  JACC, 2021
• Does left ventricular function predict cardiac outcome in Anderson–Fabry disease?
  The International Journal of Cardiovascular Imaging, 2020
• An Expert Consensus Document on the Management of Cardiovascular Manifestations of Fabry Disease
  European Journal of Heart Failure, 2020
• European expert consensus statement on therapeutic goals in Fabry disease
  Molecular Genetics and Metabolism, 2018
• Loss of base‐to‐apex circumferential strain gradient: A specific pattern of Fabry cardiomyopathy?
  Echocardiography, 2017
• Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry
  Journal of Medical Genetics, 2016
• Long time enzyme replacement therapy stabilizes obstructive lung disease and alters peripheral immune cell subsets in Fabry patients
  The Clinical Respiratory Journal, 2016
• X‐chromosome inactivation in female patients with Fabry disease
  Clinical Genetics, 2015
• Consenso para el estudio y tratamiento de la enfermedad de Fabry. Fundación GETER
  Medicina Clinica, 2011
• Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease
  New England Journal of Medicine, 2001